NFCR Writer David Perry, Author at NFCR - Page 7 of 9

NFCR Writer David Perry

Harold Dvorak: The Trailblazer

“Tumors are wounds that don’t heal,” says Harold Dvorak, M.D., and if that sounds like an overly simplification, it is a foregone conclusion that some of the most complicated problems have very simple beginnings. A scientists funded by the National Foundation for Cancer Research (NFCR) from 1980 to 2016, Dr.…...

Read more

A Skin Cancer 101

Let’s just dispel the myths now: There is no such thing as a “healthy tan.” Outside of a full suit of armor, there is no such thing as “sunblock;” in fact, the Food and Drug Administration banned the use of the term. You can get skin cancer in places that…...

Read more

Hot and Cold: A New Pancreatic Cancer Treatment?

It is established medical fact that either heating or freezing a cancer cell can kill it, but a new treatment out of the State University of New York at Binghamton (AKA Binghamton University) for pancreatic cancer involves using both, with the result being more of a whole tumor being destroyed.…...

Read more

Man Up: June Is Men’s Health Month

“Even in the face of better, more accessible detection and prevention programs, we need men to recognize and adopt healthier lifestyles,” said President Bill Clinton when he proclaimed Men’s Health Week over 20 years ago. “No health care policy can replace the benefits that American men would reap from this…...

Read more

Immunotherapy: Where We’re Headed

It is the “new territory” of oncology: Getting the immune system to successfully fight a standing cancer. No other biological system within our bodies is more suited, adept or evolved to such a purpose. Indeed, our immune system is remarkably successful in spotting and destroying the tiny genetic mutations from…...

Read more

Douglas Lowy & John Schiller: An Ounce of Prevention

When Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., receive the 2018 Albert Szent-Györgyi Prize for Cancer Research, it will set a precedent for the honor itself. By creating an effective vaccine for the human papillomavirus (HPV), cause of practically all cervical tumors, Lowy and Schiller forged a means…...

Read more

Hail, Bounteous May!

May is Cancer Research Awareness Month, a time highlighting the vital role of study and experimentation in the quest for cancer cures. As such, it is a particularly special month for the National Foundation for Cancer Research (NFCR). If fact, our Svent-Györgyi Prize for Progress in Cancer Research ceremony, NFCR’s…...

Read more

Michael Hall: TOR de Force

The discovery of rapamycin in 1972 did not create major waves in the oncology community. But in 1989, Michael N. Hall, Ph.D., took a second look, screening yeast cells for rapamycin resistance. That led to the discovery of TOR, or “Target of Rapamycin,” and one of the most profound paradigm…...

Read more

Medical Coalition Led Largely by NFCR Unites to Battle Glioblastoma

Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...

Read more

New Test Developed for Pre-Cancerous Barrett’s Esophagus

In recognition of Esophageal Cancer Awareness Month, this National Foundation for Cancer Research post offers a look at a significant diagnostic advancement for a risk factor associated with the terrible disease. A new test for Barrett’s esophagus, a precancerous forerunner of the much deadlier esophageal adenocarcinoma, is in clinical trials…...

Read more